Chapter 10
Toxicology of Nanobiomaterials
Shahin Bonakdar,
Omid Mashinchian,
Shahin Bonakdar
National Cell Bank, Pasteur Institute of Iran, Tehran, Iran
Search for more papers by this authorOmid Mashinchian
Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorShahin Bonakdar,
Omid Mashinchian,
Shahin Bonakdar
National Cell Bank, Pasteur Institute of Iran, Tehran, Iran
Search for more papers by this authorOmid Mashinchian
Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorBook Editor(s):Hossein Baharvand,
Nasser Aghdami,
Hossein Baharvand
Search for more papers by this authorNasser Aghdami
Search for more papers by this authorSummary
Research on nanostructures continues to evolve with the growth of nanotechnology for diagnostic and therapeutic clinical applications. It is imperative to determine the safety and efficacy of a nanobiomaterial for any specified application. Due to the diverse properties of nanostructures and many unrecognized factors in biological environments, selection of appropriate experiments for determination of injurious effects on biological systems must be precisely performed and interpreted. Although various techniques have been proposed for toxicity evaluation of nanomaterials, to date no single assessment is sufficient. Toxicity observation is initiated by the observation of the cell's response to a nanomaterial which has been preceded by studies in animal models for genotoxicity, immunotoxicity, carcinogenicity or hemolysis. In this text, common methods for evaluation of nanomaterial toxicity are introduced and briefly described.
References
- Portney NG and M Ozkan (2006). Nano-oncology: drug delivery, imaging, and sensing. Analytical and Bioanalytical Chemistry 384: 620–630.
- Pankhurst QA, J Connolly, SK Jones and J Dobson (2003). Applications of magnetic nanoparticles in biomedicine. Journal of Physics D: Applied Physics 36: R167.
- Yildirimer L, NTK Thanh, M Loizidou and AM Seifalian (2011). Toxicology and clinical potential of nanoparticles. Nano Today 6: 585–607.
- Hainfeld JF, DN Slatkin, TM Focella and HM Smilowitz (2006). Gold nanoparticles: a new X-ray contrast agent. British Journal of Radiology 79: 248–253.
- Everts M, V Saini, JL Leddon, RJ Kok, M Stoff-Khalili, MA Preuss, CL Millican, G Perkins, JM Brown, H Bagaria, et al. (2006). Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Letters 6: 587–591.
- Bharathi S, N Fishelson and O Lev (1999). Direct synthesis and characterization of gold and other noble metal nanodispersions in sol-gel-derived organically modified silicates. Langmuir 15: 1929–1937.
- Nel A, T Xia, L Mdler and N Li (2006). Toxic potential of materials at the nanolevel. Science 311: 622–627.
- Lieschke GJ and PD Currie (2007). Animal models of human disease: zebrafish swim into view. Nature Reviews Genetics 8: 353–367.
- Kaufman CK, RM White and L Zon (2009). Chemical genetic screening in the zebrafish embryo. Nature Protocols 4: 1422–1432.
- Bar-Ilan O, RM Albrecht, VE Fako and DY Furgeson (2009). Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5: 1897–1910.
- Karlsson HL, J Gustafsson, P Cronholm and L Möller (2009). Size-dependent toxicity of metal oxide particles-a comparison between nano-and micrometer size. Toxicology Letters 188: 112–118.
- Midander K, P Cronholm, HL Karlsson, K Elihn, L Möller, C Leygraf and IO Wallinder (2009). Surface characteristics, copper release, and toxicity of nano- and micrometer-sized copper and copper(II) oxide particles: a cross-disciplinary study. Small 5: 389–399.
- Chen Z, H Meng, G Xing, C Chen, Y Zhao, G Jia, T Wang, H Yuan, C Ye and F Zhao (2006). Acute toxicological effects of copper nanoparticles in vivo. Toxicology Letters 163: 109–120.
- Monteiro-Riviere NA and AO Inman (2006). Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44: 1070–1078.
- Bakand S, A Hayes and F Dechsakulthorn (2012). Nanoparticles: a review of particle toxicology following inhalation exposure. Inhalation Toxicology 24: 125–135.
- Buzea C, II Pacheco and K Robbie (2007). Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2: MR17–MR71.
- Schrand AM, JJ Schlager, L Dai and SM Hussain (2010). Preparation of cells for assessing ultrastructural localization of nanoparticles with transmission electron microscopy. Nature Protocols 5: 744–757.
- Na HB, IC Song and T Hyeon (2009). Inorganic nanoparticles for MRI contrast agents. Advanced Materials 21: 2133–2148.
- Sharma P, S Brown, G Walter, S Santra and B Moudgil (2006). Nanoparticles for bioimaging. Advances in Colloid and Interface Science 123–126: 471–485.
- Sohaebuddin SK, PT Thevenot, D Baker, JW Eaton and L Tang (2010). Nanomaterial cytotoxicity is composition, size, and cell type dependent. Particle and Fibre Toxicology 7: 22.
- Smith SM, MB Wunder, DA Norris and YG Shellman (2011). A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PloS One 6: e26908.
- Kim JA, C Aberg, A Salvati and KA Dawson (2012). Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nature Nanotechnology 7: 62–68.
- Walsh GM, G Dewson, AJ Wardlaw, F Levi-Schaffer and R Moqbel (1998). A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. Journal of Immunological Methods 217: 153–163.
- Chan W-H and N-H Shiao (2008). Cytotoxic effect of CdSe quantum dots on mouse embryonic development. Acta Pharmacologica Sinica 29: 259–266.
- Elmore S (2007). Apoptosis: a review of programmed cell death. Toxicologic Pathology 35: 495–516.
- Lao F, L Chen, W Li, C Ge, Y Qu, Q Sun, Y Zhao, D Han and C Chen (2009). Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit jnk-related apoptosis. ACS Nano 3: 3358–3368.
- Mahmoudi M, H Hofmann, B Rothen-Rutishauser and A Petri-Fink (2011). Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chemical Reviews 112: 2323–2338.
- Franken NAP, HM Rodermond, J Stap, J Haveman and C van Bree (2006). Clonogenic assay of cells in vitro . Nature Protocols 1: 2315–2319.
- Baudino TA, C McKay, H Pendeville-Samain, JA Nilsson, KH Maclean, EL White, AC Davis, JN Ihle and JL Cleveland (2002). c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes and Development 16: 2530–2543.
- Hsin Y-H, C-F Chen, S Huang, T-S Shih, P-S Lai and PJ Chueh (2008). The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicology Letters 179: 130–139.
- Chambers JW and PV LoGrasso (2011). Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation. Journal of Biological Chemistry 286: 16052–16062.
- Shen HM and ZG Liu (2006). JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radical Biology and Medicine 40: 928–939.
- Fridman JS and SW Lowe (2003). Control of apoptosis by p53. Oncogene 22: 9030–9040.
- Vazquez A, EE Bond, AJ Levine and GL Bond (2008). The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 7: 979–987.
- Davis ME, Z Chen and DM Shin (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery 7: 771–782.
- Senzer N, J Nemunaitis, D Nemunaitis, C Bedell, G Edelman, M Barve, R Nunan, KF Pirollo, A Rait and EH Chang (2013). Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. Molecular Therapy 21: 1096–1103.
- Meyer K, P Rajanahalli, M Ahamed, JJ Rowe and Y Hong (2011). ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicology in Vitro 25: 1721–1726.
- Wu J, J Sun and Y Xue (2010). Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. Toxicology Letters 199: 269–276.
- Ahamed M, MJ Akhtar, MA Siddiqui, J Ahmad, J Musarrat, AA Al-Khedhairy, MS AlSalhi and SA Alrokayan (2011). Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology 283: 101–108.
- Ahamed M, R Posgai, TJ Gorey, M Nielsen, SM Hussain and JJ Rowe (2010). Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster. Toxicology and Applied Pharmacology 242: 263–269.
- Huang Y, L He, W Liu, C Fan, W Zheng, Y-S Wong and T Chen (2013). Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials 34: 7106–7016.
- Downward J (1998). Ras signalling and apoptosis. Current Opinion in Genetics and Development 8: 49–54.
- Wang G, Z Nikolovska-Coleska, C-Y Yang, R Wang, G Tang, J Guo, S Shangary, S Qiu, W Gao and D Yang (2006). Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. Journal of Medicinal Chemistry 49: 6139–6142.
- Liu X and J Sun (2010). Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials 31: 8198–8209.
- Bisht S and A Maitra (2009). Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wiley Interdisciplinary Reviews in Nanomedicine and Nanobiotechnology 1: 415–425.
- Chen Y, JJ Wu and L Huang (2010). Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy. Molecular Therapy 18: 828–834.
- Dobrovolskaia MA and SE McNeil (2007). Immunological properties of engineered nanomaterials. Nature Nanotechnology 2: 469–478.
- Xiang SD, A Scholzen, G Minigo, C David, V Apostolopoulos, PL Mottram and M Plebanski (2006). Pathogen recognition and development of particulate vaccines: does size matter? Methods 40: 1–9.
- Val S, S Hussain, S Boland, R Hamel, A Baeza-Squiban and F Marano (2009). Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhalation Toxicology 21 (Suppl 1): 115–122.
- Kagan VE, NV Konduru, W Feng, BL Allen, J Conroy, Y Volkov II Vlasova, NA Belikova, N Yanamala, A Kapralov, et al. (2010). Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nature Nanotechnology 5: 354–359.
- Lamprecht A, N Ubrich, H Yamamoto, U Schäfer, H Takeuchi, P Maincent, Y Kawashima and C-M Lehr (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. Journal of Pharmacology and Experimental Therapeutics 299: 775–781.
- Howard KA, SR Paludan, MA Behlke, F Besenbacher, B Deleuran and Jr Kjems (2008). Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Molecular Therapy 17: 162–168.
- Dobrovolskaia MA, P Aggarwal, JB Hall and SE McNeil (2008). Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Molecular Pharmaceutics 5: 487–495.
- Moon JJ, B Huang and DJ Irvine (2012). Engineering nano- and microparticles to tune immunity. Advanced Materials 24: 3724–3746.
- Yoo J-W, E Chambers and S Mitragotri (2010). Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Current Pharmaceutical Design 16: 2298–2307.
- Long TC, N Saleh, RD Tilton, GV Lowry and B Veronesi (2006). Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environmental Science and Technology 40: 4346–4352.
- Limbach LK, P Wick, P Manser, RN Grass, A Bruinink and WJ Stark (2007). Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environmental Science and Technology 41: 4158–4163.
- George S, T Xia, R Rallo, Y Zhao, Z Ji, S Lin, X Wang, H Zhang, B France, D Schoenfeld, et al. (2011). Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 5: 1805–1817.
- Schrand AM, H Huang, C Carlson, JJ Schlager, E Omacr Sawa, SM Hussain and L Dai (2006). Are diamond nanoparticles cytotoxic? The Journal of Physical Chemistry B 111: 2–7.
- Gordon S (2003). Alternative activation of macrophages. Nature Reviews Immunology 3: 23–35.
- Park E-J, J Choi, Y-K Park and K Park (2008). Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245: 90–100.
- Naqvi S, M Samim, M Abdin, FJ Ahmed, A Maitra, C Prashant and AK Dinda (2010). Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. International Journal of Nanomedicine 5: 983–989.
- Jones CF and DW Grainger (2009). In vitro assessments of nanomaterial toxicity. Advanced Drug Delivery Reviews 61: 438–456.
- Liu H, D Yang, H Yang, H Zhang, W Zhang, Y Fang, Z Lin, L Tian, B Lin and J Yan (2013). Comparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: Silver, zinc oxide and titanium dioxide. Journal of Hazardous Materials 15: 248–249, 478–486.
- Carlson C, SM Hussain, AM Schrand, L K. Braydich-Stolle, KL Hess, RL Jones and JJ Schlager (2008). Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. The Journal of Physical Chemistry B 112: 13608–13619.
- Park E-J and K Park (2009). Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro . Toxicology Letters 184: 18–25.
- Schipper ML, N Nakayama-Ratchford, CR Davis, NWS Kam, P Chu, Z Liu, X Sun, H Dai and SS Gambhir (2008). A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nature Nanotechnology 3: 216–221.
- Ryman-Rasmussen JP, MF Cesta, AR Brody, JK Shipley-Phillips, JI Everitt, EW Tewksbury, OR Moss, BA Wong, DE Dodd and ME Andersen (2009). Inhaled carbon nanotubes reach the subpleural tissue in mice. Nature nanotechnology 4: 747–751.
- Landsiedel R, MD Kapp, M Schulz, K Wiench and F Oesch (2009). Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations – many questions, some answers. Mutation Research/Reviews in Mutation Research 681: 241–258.
- Dhawan A, JS Taurozzi, AK Pandey, W Shan, SM Miller, SA Hashsham and VV Tarabara (2006). Stable colloidal dispersions of C60 fullerenes in water: evidence for genotoxicity. Environmental Science and Technology 40: 7394–7401.
- Kisin ER, AR Murray, MJ Keane, X-C Shi, D Schwegler-Berry, O Gorelik, S Arepalli, V Castranova, WE Wallace and VE Kagan (2007). Single-walled carbon nanotubes: geno-and cytotoxic effects in lung fibroblast V79 cells. Journal of Toxicology and Environmental Health, Part A 70: 2071–2079.
- Wang JJ, BJ Sanderson and H Wang (2007). Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 628: 99–106.
- Mroz R, R Schins, H Li, L Jimenez, E Drost, A Holownia, W MacNee and K Donaldson (2008). Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. European Respiratory Journal 31: 241–251.
- Jacobsen NR, AT Saber, P White, P Møller, G Pojana, U Vogel, S Loft, J Gingerich, L Soper and GR Douglas (2007). Increased mutant frequency by carbon black, but not quartz, in the lacZ and cII transgenes of Muta™ Mouse lung epithelial cells. Environmental and Molecular Mutagenesis 48: 451–461.
- Vinzents PS, P Møller, M Sørensen, LE Knudsen, O Hertel, FP Jensen, B Schibye and S Loft (2005). Personal exposure to ultrafine particles and oxidative DNA damage. Environmental Health Perspectives 113: 1485.
- Green M and E Howman (2005). Semiconductor quantum dots and free radical induced DNA nicking. Chemical Communications 2005(1): 121–123.
- Li Z, T Hulderman, R Salmen, R Chapman, SS Leonard, S-H Young, A Shvedova, MI Luster and PP Simeonova (2007). Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environmental Health Perspectives 115: 377.
- Wang JJ, H Wang and BJ Sanderson (2007). Ultrafine quartz-induced damage in human lymphoblastoid cells in vitro using three genetic damage end-points. Toxicology Mechanisms and Methods 17: 223–232.
- Wang JJ, BJ Sanderson and H Wang (2007). Cytotoxicity and genotoxicity of ultrafine crystalline SiO2 particulate in cultured human lymphoblastoid cells. Environmental and Molecular Mutagenesis 48: 151–157.
- Papageorgiou I, C Brown, R Schins, S Singh, R Newson, S Davis, J Fisher, E Ingham and C Case (2007). The effect of nano- and micron-sized particles of cobalt–chromium alloy on human fibroblasts in vitro . Biomaterials 28: 2946–2958.
- Dufour EK, T Kumaravel, GJ Nohynek, D Kirkland and H Toutain (2006). Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 607: 215–224.
- Yamashita K, Y Yoshioka, K Higashisaka, K Mimura, Y Morishita, M Nozaki, T Yoshida, T Ogura, H Nabeshi, K Nagano, et al. (2011). Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nature Nanotechnology 6: 321–328.
- Ilinskaya AN and MA Dobrovolskaia (2013). Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology. Nanomedicine 8: 773–784.
- Mayer A, M Vadon, B Rinner, A Novak, R Wintersteiger and E Fröhlich (2009). The role of nanoparticle size in hemocompatibility. Toxicology 258: 139–147.
- Naeye B, H Deschout, M Rding, M Rudemo, J Delanghe, K Devreese, J Demeester, K Braeckmans, SC De Smedt and K Raemdonck (2011). Hemocompatibility of siRNA loaded dextran nanogels. Biomaterials 32: 9120–9127.
- Liu Y-Y, D-M Liu, S-Y Chen, T-H Tung and T-Y Liu (2008). In situ synthesis of hybrid nanocomposite with highly order arranged amorphous metallic copper nanoparticle in poly (2-hydroxyethyl methacrylate) and its potential for blood-contact uses. Acta Biomaterialia 4: 2052–2058.
- Tajabadi M, ME Khosroshahi and S Bonakdar (2013). An efficient method of SPION synthesis coated with third generation PAMAM dendrimer. Colloids and Surfaces A: Physicochemical and Engineering Aspects 431: 18–26.
- Duncan R and L Izzo (2005). Dendrimer biocompatibility and toxicity. Advanced Drug Delivery Reviews 57: 2215–2237.
- Agashe HB, T Dutta, M Garg and NK Jain (2006). Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. Journal of Pharmacy and Pharmacology 58: 1491–1498.
- Hoshino Y, T Urakami, T Kodama, H Koide, N Oku, Y Okahata and KJ Shea (2009). Design of synthetic polymer nanoparticles that capture and neutralize a toxic peptide. Small 5: 1562–1568.
- Petros RA and JM DeSimone (2010). Strategies in the design of nanoparticles for therapeutic applications. Nature Reviews Drug Discovery 9: 615–627.
- Peer D, JM Karp, S Hong, OC Farokhzad, R Margalit and R Langer (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology 2: 751–760.
- Hoshino Y, H Koide, K Furuya, WW Haberaecker, S-H Lee, T Kodama, H Kanazawa, N Oku and KJ Shea (2012). The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo. Proceedings of the National Academy of Sciences 109: 33–38.
- Lynch I and KA Dawson (2008). Protein–nanoparticle interactions. Nano Today 3: 40–47.
- Mahmoudi M, MA Shokrgozar, S Bonakdar, MK Moghadam and S Laurent (2011). Interaction of bare and gold-coated superparamagnetic iron oxide nanoparticles with fetal bovine serum. Journal of the Iranian Chemical Society 8: 944–950.
- Avogbe PH, L Ayi-Fanou, H Autrup, S Loft, B Fayomi, A Sanni, P Vinzents and P Møller (2005). Ultrafine particulate matter and high-level benzene urban air pollution in relation to oxidative DNA damage. Carcinogenesis 26: 613–620.
- Bräuner EV, L Forchhammer, P Møller, J Simonsen, M Glasius, P Wåhlin, O Raaschou-Nielsen and S Loft (2007). Exposure to ultrafine particles from ambient air and oxidative stress–induced DNA damage. Environmental Health Perspectives 115: 1177.
- Driscoll KE, LC Deyo, JM Carter, BW Howard, DG Hassenbein and TA Bertram (1997). Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. Carcinogenesis 18: 423–430.
- Freitas M, L Silva, R Azevedo, V Garcia, L Lacava, C Grisolia, C Lucci, P Morais, M Da Silva and N Buske (2002). A double-coated magnetite-based magnetic fluid evaluation by cytometry and genetic tests. Journal of Magnetism and Magnetic Materials 252: 396–398.
- Kim JS, T-J Yoon, KN Yu, BG Kim, SJ Park, HW Kim, KH Lee, SB Park, J-K Lee and MH Cho (2006). Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicological Sciences 89: 338–347.
- Muller J, I Decordier, PH Hoet, N Lombaert, L Thomassen, F Huaux, D Lison and M Kirsch-Volders (2008). Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells. Carcinogenesis 29: 427–433.
- Zheng Y, DJ Hunting, P Ayotte and L Sanche (2008). Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiation Research 169: 19–27; Erratum 169: 481–482.
